𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An open label study to determine the efficacy and tolerability of tegaserod in the treatment of constipation dominant irritable bowel syndrome (IBS-C)

✍ Scribed by Shah, Hasnain A.; Jafri, Wasim; Butt, Javed A.; Mohsin, Aftab; Khan, Ikramullah


Book ID
123389588
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
256 KB
Volume
124
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Duloxetine in the treatment of irritable
✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal